Pfizer Inc (NYSE:PFE)’s share price soared 0% or 0 to reach at $45.14 during previous trading session. A total of 0 shares exchanged hands, whereas the company’s average trading volume stands at 22.57 Million shares. Pfizer Inc (NYSE:PFE) has a market capitalization of $265.2 Billion and most recently 5.88 Billion outstanding shares have been calculated.

According to sentiments of 17 analysts the mean estimates of short term price target for the company’s stock is marked at $44.15. The most optimistic analyst sees the stock reaching $54 while the most conventional predicts the target price at $36.

In terms of Buy/Sell recommendations, 10 analysts have a consensus rating of 2.05 on the shares of Pfizer Inc (NYSE:PFE). Out of rating recommendations 3 have given the stock a Buy while 5 recommend the stock as Outperform. 8 have given the stock a Hold rating, 0 as Underperform and 2 as Sell.

Pfizer Inc (NYSE:PFE)’s shares climbed 2.43% in the past week and soared 5.15% in the last 4 weeks, historically the stock illustrate that its six months performance stands at 24.08% while its year to date performance is at 24.63%.

While taking a glance at financials, we can look at a number of key indicators. Pfizer Inc (NYSE:PFE) has a Return on Assets (ROA) of 14.2. The company currently has a Return on Equity (ROE) of 33.7 and a Return on Investment (ROI) of 11. Average true range (ATR-14) of the company sets at 1.01, along with its weekly and monthly volatility of 2.18% and 2.11% respectively. Relative strength index (RSI-14) for Pfizer Inc (NYSE:PFE) is at 55.52. Beta value of the stock stands at 0.86.

The company’s price to free cash flow for trailing twelve months is 27.1. Its quick ratio for most recent quarter is 1.2 along with current ratio for most recent quarter of 1.4. Total debt to equity ratio of Pfizer Inc (NYSE:PFE) for most recent quarter is 0.58 whereas long term debt to equity ratio for most recent quarter is 0.47.

Shares of Celgene Corp (NASDAQ:CELG) soared 0% or 0 to reach at $72.47 during previous trading session. Celgene Corp (NASDAQ:CELG) has a market capitalization of $50.87 Billion and most recently 702 Million outstanding shares have been calculated. A total of 0 shares exchanged hands, whereas the company’s average trading volume stands at 5.72 Million shares.

According to 24 analysts Celgene Corp (NASDAQ:CELG)’s price will reach at $107.9 during 52 weeks. Stock’s minimum price target estimates has been figured out at $71 while the maximum price target forecast is established at $163.

According to the recommendations from 18 analysts stock has mean rating of 1.72 on the shares of Celgene Corp (NASDAQ:CELG). Out of rating recommendations 10 have given the stock a Buy while 7 recommend the stock as Outperform. 9 have given the stock a Hold rating, 1 as Underperform and 0 as Sell.

Shares of Celgene Corp (NASDAQ:CELG) climbed 4.74% in the past week and plunged -2.32% in the last 4 weeks, historically the stock illustrate that its six months performance stands at -8.02% while its year to date performance is at -30.56%.

Total debt to equity ratio of Celgene Corp (NASDAQ:CELG) for most recent quarter is 4.17 whereas long term debt to equity ratio for most recent quarter is 4.06. The company’s price to free cash flow for trailing twelve months is 12.16. Its quick ratio for most recent quarter is 2 along with current ratio for most recent quarter of 2.1.

Average true range (ATR-14) of the company sets at 2.26, along with its weekly and monthly volatility of 3.29% and 2.69% respectively. Relative strength index (RSI-14) for Celgene Corp (NASDAQ:CELG) is at 48.41. Beta value of the stock stands at 1.51. Celgene Corp (NASDAQ:CELG) has a Return on Assets (ROA) of 8.7. The company currently has a Return on Equity (ROE) of 56.8 and a Return on Investment (ROI) of 20.